+ , crystallised as the hexafluorophosphate salt, has been established by single crystal X-ray diffraction. The complexes are highly cytotoxic against human ovarian cancer cells (cell lines A2780 and A2780cisR), with the IC 50 values being in the submicromolar range. In comparison the analogous trishydroxythiophenolato compounds [(arene) 2 Ru 2 (S-p-C 6 H 4 OH) 3 ]Cl (IC 50 values around 100 mM) are much less cytotoxic. Thus, it would appear that the increased antiproliferative effect of the arene ruthenium complexes is due to the presence of the phenyl or toluyl substituents at the three thiolato bridges.
Introduction
Water-soluble arene ruthenium complexes such as the prototype (pi PrC 6 H 4 Me)Ru(P-pta)Cl 2 (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane) (termed RAPTA-C) 1 and lipophilic compounds such as the benchmark [(C 6 H 5 Ph)Ru(N,Nen)Cl] + (en = 1,2-ethylenediamine) 2 have antitumoral or antimetastatic properties in vitro and in vivo. The anticancer potential of these types of compounds has been explained by their dual character, with the hydrogen bonding capacity of the pta or en ligands counterbalanced by the lipophilicity of the arene ligand, 3 while the mechanism of cytotoxic action is thought to involve hydrolysis of the Ru-Cl bond followed by reaction with the biomolecular target or targets. 4 The underlying design of arene ruthenium anticancer agents and the current understanding of their mode of action is summarised in several review articles.
5-9
While most cytotoxicity studies with arene ruthenium compounds have been concerned with mononuclear complexes, the question of applying the multinuclearity concept to arene ruthenium complexes was recently raised, 10 in the light of an increased cytotoxicity of trinuclear arene ruthenium cluster cations.
11 This is indeed confirmed by recent findings with highly active dinuclear arene ruthenium complexes: the dinuclear arene ruthenium complexes (pi PrC 6 colon (SW480) cancer cell lines. A pronounced influence of the spacer length and cytotoxicity was found (A2780 IC 50 25 mM for n = 3, 30 mM for n = 6, 1.5 mM for n = 12, SW480 IC 50 62 mM for n = 3, 26 mM for n = 6, 0.3 mM for n = 12), with the cytotoxicity being correlated with lipophilicity and water solubility.
12, 13 A detailed structure-activity relationship was established based on water/octanol partition and hydrolytic stability, showing that only the most lipophilic (long) chain (n = 12) is highly active, due to the ability of the compound to cross-link with biomolecules.
14 This is in agreement with the cytotoxicities we observed for dinuclear ferrocenyl pyridine arene ruthenium complexes [ Fig. 1 ) readily undergo arene loss upon UV irradiation whereas the p-cymene and hexamethylbenzene derivatives do not. The indane derivative undergoes aquation in the dark, and UV or visible light leads to a dissociation of the indane ligand and to the formation of strong diruthenium DNA adducts.
16
Based on our earlier work on dinuclear arene ruthenium complexes of the type [(arene) 2 3 ] + , which in the form of their chloride salts proved to be highly active against human ovarian cancer cell lines, with the cytotoxicity being in the submicromolar range. 
Results and discussion

Synthesis and characterisation of the diene precursors 1-4
The compounds 2-(cyclohexa-1,4-dienyl)ethanol and 4-(cyclohexa-1,4-dienyl)butanol, accessible by Birch reduction of the corresponding benzene derivatives, 22,23 react in the presence of 4-(dimethylamino)pyridine, N,N¢-dicyclohexylcarbodiimide and 4-pyrrolidinopyridine as coupling reagents, with 4-(heptyloxy)benzoic acid to give the functionalised dienes 1 and 2, using conditions similar to those reported previously. 24 The coupling with 4-methoxycinnamic acid under the same conditions yields to the functionalised dienes 3 and 4 (Scheme 1). The new compounds, obtained as colorless oils, were characterised by NMR spectroscopy, mass spectrometry and elemental analysis (see Experimental).
Synthesis and characterisation of the functionalised arene ruthenium chloro intermediates 5-8
The complexes [ 
Synthesis and characterisation of the unfunctionalised arene ruthenium thiophenolato complexes 17-19
In order to study the influence of the lipophilic chains in the arene ligands on the biological activity, we also synthesised the unfunctionalised cation [(C 6 2 ) were also synthesised according to this method which gives much better yields than the reported procedures. All the complexes were isolated as the chloride salts.
Compound [17] Cl, an air-stable yellow solid soluble in water and in organic solvents, gives rise to two signals for the three equivalent thiophenolato groups (7.37 m and 7.83 d ppm) and to a singlet for the two equivalent benzene Scheme 5 Synthesis of the unfunctionalised diruthenium complex 17. . The ESI mass spectrum shows the molecular peak at m/z 686.94. The spectroscopic data for the analogues [18] Cl, [19] Cl and [20] Cl are in excellent agreement with those reported previously.
25,26,18
The molecular structure of 17 was established by single-crystal X-ray diffraction analysis of the PF 6 -salt. The unit cell contains two independent cations (molecules A and B), the bond distances and angles being similar. An ORTEP drawing with the atom labelling scheme for molecule A of cation 17 is shown in Fig. 3 and selected bond lengths and angles are given in Table 1 . The structure contains a trigonal bipyramidal Ru 2 S 3 framework, in which each ruthenium atom adopts a pseudo-octahedral geometry due to the three sulfur atoms and the benzene ligand that formally occupies three coordination sites.
The Ru-S bond distances in the cation 17 range from 2.3764 (12) 27 In accordance with the electron count, the Ru-Ru distances (3.3576(5) and 3.3481(6)Å) are clearly outside of the range for a metal-metal single bond (2.28-2.95Å). 24 The three phenyl groups are not in the plane formed by the three sulfur atoms. The difference between the two independent molecules resides in the relative tilt of the phenyl groups with respect to this plane; in molecule A two phenyl groups are tilted to the right and the third phenyl group is tilted to the left whereas the tilts are opposite in molecule B.
Biological activity towards human ovarian cancer cells
The antiproliferative activity of complexes 9-20 was evaluated against the human ovarian A2780 cancer cell line and its cisplatinresistant derivative A2780cisR using the MTT assay, which measures mitochondrial dehydrogenase activity as an indication of cell viability. The IC 50 values of 9-20, corresponding to inhibition of cancer cell growth at the 50% level, are listed in Table 2 .
The complexes tested show a broad range of cytotoxicities, depending on both the thiophenyl and arene substituents, but with comparable effects on both the cisplatin sensitive and resistant cell lines. More precisely, two general tendencies can be appreciated from the data. First, the arene ruthenium thiophenato complexes (9 to 12) are systematically more cytotoxic than their hydroxylthiophenato analogues (13 to 16). Second, the arene moiety has an effect, as shown by the diversity of toxicities observed for compounds 9, 10, 17, 18, 19 and 20, although the IC 50 values obtained cannot be precisely correlated to the lipophilicity or the size of the substituents. It is worth noting that the sub-micromolar cytotoxicities observed for some of these compounds place them amongst the most cytotoxic arene ruthenium compounds reported, even based on the fact that two ruthenium centers are present.
The In conclusion, a series of highly cytotoxic cationic diruthenium complexes of general formula [(arene) 2 Ru 2 (SPh) 3 ]
+ have been prepared. The high in vitro anticancer activity of these complexes must be ascribed, at least in part, to the presence of the thiophenolato groups. Further work is required to delineate the mode of action of these compounds and to develop further derivatives in order to understand the role of the bridging thiophenolato ligands.
Experimental General comments
All reagents were purchased either from Aldrich or Fluka and used as received. The dimers [(arene) 2 RuCl 2 ] 2 28 were prepared according to literature methods. Reactions were carried out under nitrogen. NMR spectra were recorded on a Bruker AMX 400 spectrometer using the residual protonated solvent as internal standard. Micro-analyses were performed by the Laboratory of Pharmaceutical Chemistry, University of Geneva (Switzerland) or by Mikroelementaranalytisches Laboratorium, ETH Zürich (Switzerland). Electrospray ionisation mass spectra were obtained in positive-ion mode with an LCQ Finnigan mass spectrometer or performed at the Department of Chemistry of the University of Fribourg (Switzerland).
Preparation of the diene precursors 1-4
To a Schlenk tube, the corresponding acid (5.2 mmol, 1.24 g for 1; 4.3 mmol, 1.01 g for 2; 5.2 mmol, 934 mg for 3; 4.3 mmol, 761 mg for 4), in the presence of the coupling reagents 4-(dimethylamino)pyridine (4 mmol, 492 mg for 1 and 3; 3.3 mmol, 401 mg for 2 and 4), N,N¢-dicyclohexylcarbodiimide (8 mmol, 1.66 g for 1 and 3; 6.6 mmol, 1.36 g for 2 and 4) and 4-pyrrolidinopyridine (4 mmol, 597 mg for 1 and 3; 3.3 mmol, 497 mg for 2 and 4) were dissolved in CH 2 Cl 2 (100 mL). After the addition of a solution of the diene (4 mmol, 500 mg for 1 and 3; 3.3 mmol, 500 mg for 2 and 4) in CH 2 Cl 2 (10 mL), the reaction was stirred at 20
• C during 18 h. Then resulting mixture was filtered through Celite and the solvent was removed under reduced pressure. The resulting oil was purified by column chromatography (silica gel, CH 2 Cl 2 -EtOH 4.8 : 0.2); compounds 1-4 were isolated as colorless oils and dried in vacuo. the product was precipitated by addition of diethyl ether (50 mL), isolated by filtration and dried in vacuo. 
5.
Preparation of the arene ruthenium thiophenolato complexes 9-12
The dinuclear dichloro complex [(arene) 2 RuCl 2 ] 2 (0.15 mmol, 150 mg for 9, 162 mg for 10, 136 mg for 11, 144 mg for 12) was refluxed in technical grade EtOH (50 mL). As soon as the starting material was completely dissolved, a solution of thiophenol (0.9 mmol, 99 mg, 92 mL) in technical grade EtOH (5 mL) was added dropwise to the hot solution. The resulting mixture was refluxed in EtOH for 18 h. After cooling to 20
• C, the solvent was removed under reduced pressure. The mixture was purified by column chromatography (silica gel, CH 2 Cl 2 -EtOH 5 : 1), and the compounds [9] [10] [11] [12] Cl were isolated as air-stable orange to red crystalline solids and dried in vacuo.
[ 
Preparation of the arene ruthenium thiophenolato complexes 13-16
The dinuclear dichloro complex [(arene) 2 RuCl 2 ] 2 (0.05 mmol, 50 mg for 13, 54 mg for 14, 45 mg for 15, 48 mg for 16) was refluxed in technical grade EtOH (50 mL). As soon as the starting material was completely dissolved, a solution of phydroxythiophenol (0.3 mmol, 38 mg) in technical grade EtOH (5 mL) was added dropwise to the hot solution. The resulting mixture was refluxed in EtOH for 18 h. After cooling to 20
• C, the solvent was removed under reduced pressure. The mixture was purified by column chromatography (silica gel, CH 2 Cl 2 -EtOH 5 : 1) and [13] [14] [15] [16] Cl were isolated as air-stable yellow to orange crystalline solids and dried in vacuo.
Cell culture and inhibition of cell growth
Human A2780 and A2780cisR ovarian carcinoma cells were obtained from the European Centre of Cell Cultures (ECACC, Salisbury, UK) and maintained in culture as described by the provider. The cells were routinely grown in RPMI 1640 medium with GlutaMAX TM containing 5% foetal calf serum (FCS) and antibiotics (penicillin and streptomycin) at 37
• C and 5% CO 2 . For the evaluation of growth inhibition tests, the cells were seeded in 96-well plates (25 ¥ 10 3 cells per well) and grown for 24 h in complete medium. Complexes were dissolved in DMSO and added to the required concentration to the cell culture for 72 h incubation. Solutions of the compounds were applied by diluting a freshly prepared stock solution of the corresponding compound in aqueous RPMI medium with GlutaMAX TM (20 mM) . Following drug exposure, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to the cells at a final concentration of 0.25 mg mL -1 and incubated for 2 h, then the culture medium was aspirated and the violet formazan (artificial chromogenic precipitate of the reduction of tetrazolium salts by dehydrogenases and reductases) dissolved in DMSO. The optical density of each well (96-well plates) was quantified three times in triplicates at 540 nm using a multiwall plate reader (iEMS Reader MF, Labsystems, US), and the percentage of surviving cells was calculated from the ratio of absorbance of treated to untreated cells. The IC 50 values for the inhibition of cell growth were determined by fitting the plot of the logarithmic percentage of surviving cells against the logarithm of drug concentration using a linear regression function. The median value and the median absolute deviation were obtained from the Excel TM software (Microsoft  TM ) and those values are reported in Table 2 .
Single-crystal X-ray structure analysis
A crystal of [17] PF 6 , prepared by diffusion of a dichloromethane solution of [17] Cl in the presence of KPF 6 into a diethyl ether layer, was mounted on a Stoe Image Plate Diffraction system equipped with a f circle goniometer, using Mo-Ka graphite monochromated radiation (l = 0.71073Å) with f range 0-200 • . The structure was solved by direct methods using the program SHELXS-97, while the refinement and all further calculations were carried out using SHELXL-97. 29 The H-atoms were included in calculated positions and treated as riding atoms using the SHELXL default parameters. The non-H atoms were refined anisotropically, using weighted full-matrix least-square on F 2 . Crystallographic details are summarised in Table 3 . Fig. 2 was drawn with ORTEP. 
